NCT02338648View on ClinicalTrials.gov

Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Chalazion
Interventions
DRUG

SUN-131 1.5% TDS

Active transdermal patch

DRUG

Placebo TDS

Placebo transdermal patch for blinding

Trial Locations (6)

10029

Icahn School of Medicine at Mount Sinai, New York

20037

George Washington University Medical Faculty Association, Washington D.C.

23502

Virginia Eye Consultants, Norfolk

27262

Cornerstone Eye Care, High Point

80120

Corneal Consultants of Colorado, P.C., Littleton

92705

WCCT Global Ophthalmology Research, Santa Ana

All Listed Sponsors
lead

Senju USA, Inc.

INDUSTRY

NCT02338648 - Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion | Biotech Hunter | Biotech Hunter